Mon, 17 June 2019
Pfizer buys Array Biopharma for $11.4 billion, sending shares of Array up 57%. Ron Gross analyzes the acquisition spree among big pharmaceutical companies. Target has a massive outage over the weekend, but we still have a few more questions about why. Plus, we dip into the Fool Mailbag and discuss the latest news from Papa John’s.
Thanks to Sprout Social for supporting Motley Fool. To learn how your brand can create real connection, visit sproutsocial.com/fool today.